FDA Adverse Event Malfunction Summary report: N

FINELINE II

MDR report key: 2780721 · Received October 10, 2012

Report

Report Number
2124215-2012-13334
Event Type
Malfunction
Date Received
October 10, 2012
Date of Event
September 17, 2012
Report Date
September 17, 2012
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS RIGHT ATRIAL (RA) LEAD FELL DURING A SYNCOPAL EPISODE. AFTER THE FALL, LOW P WAVES, LOSS OF CAPTURE AND SENSING OF VENTRICULAR EVENTS ON THE ATRIAL CHANNEL WERE OBSERVED. IT WAS SUSPECTED THAT THE LEAD HAD DISLODGED. IT WAS NOTED THAT THE PATIENT WAS NOT PACEMAKER DEPENDANT AND THERE WERE NO ALLEGATIONS RELATED TO THE PATIENT SYNCOPE. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) REVIEWED THE ELECTROGRAMS (EGMS) AND NOTED WHAT APPEARED TO BE A NORMAL VENTRICULAR TACHYCARDIA (VT) OR SUPRAVENTRICULAR TACHYCARDIA (SVT) EVENT ON THE DAY OF THE PATIENT FALL. ADDITIONAL INFORMATION WAS PROVIDED THAT A LEAD DISLODGEMENT WAS CONFIRMED AND THE DEVICE WAS PROGRAMMED TO VVI. THE PATIENT WILL CONTINUE TO BE MONITORED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4480

Patients

Seq Age Sex Outcome Treatment
1 80 YR K173| 4457| 4480